BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21219825)

  • 1. [Effect of Src tyrosine kinase inhibition on secretion of MMP-2 and MMP-9 by non-small cell lung cancer cells].
    Zheng R; Qin X; Li W; Kang J
    Zhongguo Fei Ai Za Zhi; 2011 Jan; 14(1):13-7. PubMed ID: 21219825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of Src on proliferation and invasion of lung cancer cells].
    Zheng R; Qin X; Li W; Kang J
    Zhongguo Fei Ai Za Zhi; 2011 Apr; 14(4):311-6. PubMed ID: 21496428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SRC tyrosine kinase inhibitor, m475271, suppresses subcutaneous growth and production of lung metastasis via inhibition of proliferation, invasion, and vascularization of human lung adenocarcinoma cells.
    Zheng R; Yano S; Matsumori Y; Nakataki E; Muguruma H; Yoshizumi M; Sone S
    Clin Exp Metastasis; 2005; 22(3):195-204. PubMed ID: 16158247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derlin-1 is overexpressed in non-small cell lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated up-regulation of MMP-2 and MMP-9.
    Dong QZ; Wang Y; Tang ZP; Fu L; Li QC; Wang ED; Wang EH
    Am J Pathol; 2013 Mar; 182(3):954-64. PubMed ID: 23306155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ZD6474, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, inhibits growth of experimental lung metastasis and production of malignant pleural effusions in a non-small cell lung cancer model.
    Matsumori Y; Yano S; Goto H; Nakataki E; Wedge SR; Ryan AJ; Sone S
    Oncol Res; 2006; 16(1):15-26. PubMed ID: 16783964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timosaponin AIII inhibits migration and invasion of A549 human non-small-cell lung cancer cells via attenuations of MMP-2 and MMP-9 by inhibitions of ERK1/2, Src/FAK and β-catenin signaling pathways.
    Jung O; Lee J; Lee YJ; Yun JM; Son YJ; Cho JY; Ryou C; Lee SY
    Bioorg Med Chem Lett; 2016 Aug; 26(16):3963-7. PubMed ID: 27422337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-106a targets autophagy and enhances sensitivity of lung cancer cells to Src inhibitors.
    Rothschild SI; Gautschi O; Batliner J; Gugger M; Fey MF; Tschan MP
    Lung Cancer; 2017 May; 107():73-83. PubMed ID: 27372519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of cathepsin S and matrix metalloproteinase-9 via Src, a non-receptor tyrosine kinase, suppresses triple-negative breast cancer growth and metastasis.
    Gautam J; Banskota S; Lee H; Lee YJ; Jeon YH; Kim JA; Jeong BS
    Exp Mol Med; 2018 Sep; 50(9):1-14. PubMed ID: 30185799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-17A/IL-17RA promotes invasion and activates MMP-2 and MMP-9 expression via p38 MAPK signaling pathway in non-small cell lung cancer.
    Wu Z; He D; Zhao S; Wang H
    Mol Cell Biochem; 2019 May; 455(1-2):195-206. PubMed ID: 30564960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Src kinase inhibition induced by dasatinib in non-small cell lung cancer cell lines treated with cisplatin.
    Ceppi P; Papotti M; Monica V; Lo Iacono M; Saviozzi S; Pautasso M; Novello S; Mussino S; Bracco E; Volante M; Scagliotti GV
    Mol Cancer Ther; 2009 Nov; 8(11):3066-74. PubMed ID: 19861409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LATS2 as a poor prognostic marker regulates non-small cell lung cancer invasion by modulating MMPs expression.
    Wu A; Li J; Wu K; Mo Y; Luo Y; Ye H; Mai Z; Guo K; Wang Y; Li S; Chen H; Luo W; Yang Z
    Biomed Pharmacother; 2016 Aug; 82():290-7. PubMed ID: 27470365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinatorial treatment using targeted MEK and SRC inhibitors synergistically abrogates tumor cell growth and induces mesenchymal-epithelial transition in non-small-cell lung carcinoma.
    Chua KN; Kong LR; Sim WJ; Ng HC; Ong WR; Thiery JP; Huynh H; Goh BC
    Oncotarget; 2015 Oct; 6(30):29991-30005. PubMed ID: 26358373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depsipeptide a histone deacetlyase inhibitor down regulates levels of matrix metalloproteinases 2 and 9 mRNA and protein expressions in lung cancer cells (A549).
    Vinodhkumar R; Song YS; Ravikumar V; Ramakrishnan G; Devaki T
    Chem Biol Interact; 2007 Feb; 165(3):220-9. PubMed ID: 17240363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of Src tyrosine kinase inhibition on the drug-resistance as well as MDR1 and LRP expression of the human cis-platinum-resistant lung cancer cell line A549/DDP].
    Lv J; Tian Y
    Zhongguo Fei Ai Za Zhi; 2012 Sep; 15(9):501-6. PubMed ID: 22989452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-mobility group box 1-mediated matrix metalloproteinase-9 expression in non-small cell lung cancer contributes to tumor cell invasiveness.
    Liu PL; Tsai JR; Hwang JJ; Chou SH; Cheng YJ; Lin FY; Chen YL; Hung CY; Chen WC; Chen YH; Chong IW
    Am J Respir Cell Mol Biol; 2010 Nov; 43(5):530-8. PubMed ID: 19933377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tomatidine inhibits invasion of human lung adenocarcinoma cell A549 by reducing matrix metalloproteinases expression.
    Yan KH; Lee LM; Yan SH; Huang HC; Li CC; Lin HT; Chen PS
    Chem Biol Interact; 2013 May; 203(3):580-7. PubMed ID: 23566884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroidal saponins from Paris polyphylla suppress adhesion, migration and invasion of human lung cancer A549 cells via down-regulating MMP-2 and MMP-9.
    He H; Zheng L; Sun YP; Zhang GW; Yue ZG
    Asian Pac J Cancer Prev; 2014; 15(24):10911-6. PubMed ID: 25605200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic cell growth inhibition by the combination of amrubicin and Akt-suppressing tyrosine kinase inhibitors in small cell lung cancer cells: implication of c-Src and its inhibitor.
    Ueda Y; Igishi T; Hashimoto K; Suyama H; Araki K; Sumikawa T; Takeda K; Nakazaki H; Matsunami K; Kodani M; Shigeoka Y; Matsumoto S; Shimizu E
    Int J Oncol; 2009 Mar; 34(3):689-96. PubMed ID: 19212674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol inhibits human lung adenocarcinoma cell metastasis by suppressing heme oxygenase 1-mediated nuclear factor-kappaB pathway and subsequently downregulating expression of matrix metalloproteinases.
    Liu PL; Tsai JR; Charles AL; Hwang JJ; Chou SH; Ping YH; Lin FY; Chen YL; Hung CY; Chen WC; Chen YH; Chong IW
    Mol Nutr Food Res; 2010 Jul; 54 Suppl 2():S196-204. PubMed ID: 20461740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic effects of natural and semisynthetic cucurbitacins on lung cancer cell line A549.
    Silva IT; Geller FC; Persich L; Dudek SE; Lang KL; Caro MS; Durán FJ; Schenkel EP; Ludwig S; Simões CM
    Invest New Drugs; 2016 Apr; 34(2):139-48. PubMed ID: 26780083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.